Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.05 is 87% below its 1-year average of 24.04, near the low end of its 1-year range (3.05–64.96).
As of the fiscal period ended Wednesday, December 31, 2025. 87.33% below its 12-month average of 24.04.
Reported quarterly quick ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 3.05.
QUICK RATIO (ACID-TEST)
3.05
QUICK RATIO (ACID-TEST) AVG TTM
24.04
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-87.33%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-9.10%
vs the sector median at left
SL Science Holding Ltd
Market Cap
$852.35M
Quick Ratio (Acid-Test)
3.05
TTM Avg
24.04
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$853.13M
Quick Ratio (Acid-Test)
1.79
TTM Avg
2.17
3Y Avg
1.93
5Y Avg
2.04
Market Cap
$857.16M
Quick Ratio (Acid-Test)
0.76
TTM Avg
0.79
3Y Avg
0.88
5Y Avg
1.73
Market Cap
$838.62M
Quick Ratio (Acid-Test)
4.03
TTM Avg
6.29
3Y Avg
5.71
5Y Avg
7.79
Market Cap
$838.16M
Quick Ratio (Acid-Test)
7.96
TTM Avg
6.81
3Y Avg
6.62
5Y Avg
6.62
Market Cap
$867.03M
Quick Ratio (Acid-Test)
7.55
TTM Avg
6.94
3Y Avg
6.93
5Y Avg
8.87
Market Cap
$870.81M
Quick Ratio (Acid-Test)
11.36
TTM Avg
7.20
3Y Avg
7.20
5Y Avg
7.20
Market Cap
$833.81M
Quick Ratio (Acid-Test)
9.52
TTM Avg
4.26
3Y Avg
6.09
5Y Avg
7.80
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SL Science Holding Ltd (SLBT) | $852.35M | 3.05 | 24.04 | N/A | N/A |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 1.79 | 2.17 | 1.93 | 2.04 |
| Alumis Inc. (ALMS)vs › | $855.38M | 6.74 | 5.17 | 5.15 | 5.15 |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | 0.76 | 0.79 | 0.88 | 1.73 |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | 4.03 | 6.29 | 5.71 | 7.79 |
| Beta Bionics, Inc. (BBNX)vs › | $838.16M | 7.96 | 6.81 | 6.62 | 6.62 |
| SI-BONE, Inc. (SIBN)vs › | $867.03M | 7.55 | 6.94 | 6.93 | 8.87 |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $870.81M | 11.36 | 7.20 | 7.20 | 7.20 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $833.81M | 9.52 | 4.26 | 6.09 | 7.80 |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $828.48M | 25.06 | 12.67 | 12.67 | 12.67 |
Quick Ratio
3.05
Excludes inventory
Current Ratio
3.05
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-12-31 | 3.05 |
| 2025-06-30 | 4.11 |
| 2024-12-31 | 64.96 |
